Tekla Life Sciences Investors (HQL)

US · Financial Services · Asset Management

$19.57+1.50%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue

$48.1M

Revenue YoY

+2227.6%

Net profit

$65.3M

Profit YoY

+30.0%

EPS

$4.38

EPS estimate

$0.00

Net margin

135.9%

Key statistics

Market cap

$618.5M

P/E

3.0

Forward P/E

0.0

P/B

1.07

Book value

$18.44

EPS (TTM)

$6.64

Dividend yield

9.65%

52-week high

$22.04

52-week low

$12.28

50-day MA

$20.47

200-day MA

$18.02

Beta

0.72

Shareholding

Insiders

0.00%

Institutions

26.47%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Tekla Life Sciences Investors — free to start.

Google Play App Store

Other Financial Services companies

Berkshire Hathaway Inc Berkshire Hathaway Inc JPMorgan Chase & Co Visa Inc. Class A Mastercard Inc Bank of America Corp HSBC Holdings PLC ADR Morgan Stanley Goldman Sachs Group Inc Royal Bank of Canada Wells Fargo & Company Mitsubishi UFJ Financial Group Inc ADR

Data updated 2026-09-18.